197 results on '"Heinemann, Klaas"'
Search Results
2. Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12
3. Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study
4. Venous Thromboembolic Risk of Estradiol Valerate–Dienogest Compared with Ethinyl Estradiol–Levonorgestrel Combined Oral Contraceptives
5. Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis
6. Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study
7. Response to letter to the Editor
8. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA)
9. WITHDRAWN: Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12
10. NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.
11. NOMAC-E2 shows a better contraceptive effectiveness than LNG combined oral contraceptives in women under 25: real-world PRO-E2 study.
12. Comparing the Cardiovascular Risk of Norethindrone Acetate & Levonorgestrel Pills: Is There a Difference? [10I]
13. Impact of estrogen type on cardiovascular safety of combined oral contraceptives
14. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives
15. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices
16. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices
17. Pregnancy and pregnancy outcomes in a prospective cohort study: Final results from the Nexplanon Observational Risk Assessment Study (NORA)
18. How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?
19. Pregnancy and pregnancy outcomes in a prospective cohort study: Final results from the Nexplanon Observational Risk Assessment Study (NORA)
20. Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12
21. TEMPORARILY WITHDRAWN: Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS12
22. Nexplanon Procedure-Related Events: Final Results From the Nexplanon Observational Risk Assessment Study (NORA) [9G]
23. Ethinyl estradiol 20 μg/drospirenone 3 mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder
24. Thromboembolic Safety of Norethisterone vs Levonorgestrel in Combined Oral Contraceptive Users: A Pooled Analysis of Four Large Prospective Cohort Studies
25. The effect of premenstrual symptoms on activities of daily life
26. Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study
27. Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism
28. Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study
29. Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: Implications for the development of new hormonal endometriosis and uterine fibroid therapies
30. sj-pdf-1-pev-10.1177_22840265211035993 – Supplemental material for Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study
31. Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study
32. Ectopic Pregnancies under IUD Use: Interim Results from the EURAS-IUD Study: 855.
33. COMPARING THE CARDIOVASCULAR RISK OF NORETHINDRONE ACETATE- AND LEVONORGESTREL-CONTAINING ORAL CONTRACEPTIVES: IS THERE A DIFFERENCE?
34. ESTRADIOL IS ASSOCIATED WITH DECREASED CARDIOVASCULAR RISK COMPARED TO ETHINYLESTRADIOL WHEN CONTAINED IN COMBINED HORMONAL PREPARATIONS: IMPLICATIONS FOR THE DEVELOPMENT OF NEW ENDOMETRIOSIS THERAPIES
35. Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: Results from the extended INAS-SCORE study
36. Health care differences across Europe concerning routine IUD Surveillance: Results of the EURAS-IUD study
37. Scale for Quality of Sexual Function (QSF) as an Outcome Measure for Both Genders?
38. Attitudes toward male fertility control: results of a multinational survey on four continents
39. Sweating Attacks: Key Symptom in Menopausal Transition Only for Women?
40. Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study
41. IUD use among parous women and risk of uterine perforation: a secondary analysis
42. The Menopause Rating Scale (MRS) scale: A methodological review
43. Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study
44. Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis
45. Fertility and combined oral contraceptives – unintended pregnancies and planned pregnancies following oral contraceptive use – results from the INAS-SCORE study
46. Comparative Contraceptive Effectiveness of Levonorgestrel-Releasing and Copper Intrauterine Devices
47. Fertility and combined oral contraceptives - unintended pregnancies and planned pregnancies following oral contraceptive use - results from the INAS-SCORE study.
48. Intrauterine Devices and the Risk of Uterine Perforations
49. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives
50. Zu Leberkrebs und Arbeitsplatzexposition bei Frauen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.